Cortisol Metabolism in Human Obesity: Impaired Cortisone→Cortisol Conversion in Subjects with Central Adiposity1
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
For a given body mass index (BMI), mortality is higher in patients with central compared to generalized obesity. Glucocorticoids play an important role in determining body fat distribution, but circulating cortisol concentrations are reported to be normal in obese patients. Our recent studies show enhanced conversion of inactive cortisone (E) to active cortisol (F) through the expression of 11beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) in cultured omental adipose stromal cells; the autocrine production of F may be a crucial factor in the pathogenesis of central obesity. We have now analyzed F metabolism in subjects with BMIs between 20-25 kg/m2 (group A), 25-30 kg/m2 (group B), and more than 30 kg/m2 (group C; n 12 in each group; six males and six premenopausal females; aged 23-44 yr). Glucose/insulin were measured using a 75-g oral glucose tolerance test, and each subject had total body and regional fat (scapular, waist, hip, and thigh) quantified using dual energy x-ray absorptiometry. Urinary total F metabolites (measured by gas chromatography/mass spectrometry) were increased in subjects with obesity [group A, 11,176 +/- 1,530 microg/24 h (mean +/- SE); group C, 13,661 +/- 1,444], although not significantly so (P = 0.08). There was a significant reduction in the urinary tetrahydrocortisol (THF) +/- 5alpha-THF/tetrahydrocortisone (THE) and the cortol/cortolone ratio in obesity (group A vs. C, 1.06 +/- 0.08 vs. 0.84 +/- 0.04 and 0.41 +/- 0.03 vs. 0.34 +/- 0.03, respectively; both P < 0.05). Urinary free F (UFF) excretion was similar in all three groups, as was the UFF/urinary free E (UFE) ratio. The 0900 h circulating F, E, and ACTH pre- and postovernight 1-mg dexamethasone suppression values were similar in all three groups, but a reduction in the generation of serum F from dexamethasone-suppressed values after oral cortisone acetate (25 mg) was evident in both obese groups [e.g. 546 +/- 37 nmol/L in group A vs. 412 +/- 40 in group B (P < 0.05) and 388 +/- 38 in group C (P < 0.01) 180 min post-E]. Insulin resistance was present in groups B and C, but regression analysis revealed no relationship between F metabolites or the THF +/- 5alpha-THF/THE ratio and insulin action (homeostasis model assessment analysis and insulin values in the oral glucose tolerance test). There was, however, a highly significant relationship between the THF +/- 5alpha-THF/THE ratio and BMI (t = -3.44; P < 0.01) and total body fat (t = -2.27; P < 0.05). Stepwise regression analyses indicated an inverse relationship between THF+/-5alpha-THF/THE and scapular and waist fat (t = -2.25; P = 0.03) and a direct relationship with hip and thigh fat (t = 2.42; P = 0.02) in both sexes. The fall in the THF + 5alpha-THF/THE ratio but unchanged UFF/UFE ratio together with impaired F concentrations after oral E indicates inhibition of 11betaHSD1 in subjects with obesity. This results in an increased MCR for F, explaining the increased F secretion rate in obesity in the face of normal circulating F concentrations. 11BetaHSD1 activity is highly related to body fat distribution, with android or central obesity, but not gynoid obesity, associated with reduced activity in both sexes. This reduction in 11betaHSD1 activity raises new questions as to the primary role of 11betaHSD1 in the pathogenesis of insulin resistance and central obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As surrogate measures of adverse metabolic risk (27), AVF and omental fat-cell size have been associated in some but not all studies with increased activity or expression of 11β-hydroxysteroid dehydrogenase type 1, which promotes conversion of inactive cortisone to active cortisol (28–31).”
From Glucose ingestion selectively amplifies ACTH and cortisol secretory-burst mass and enhances their joint synchrony in healthy men. (2011) · cites this paper as [31]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
Does central obesity reflect “Cushing's disease of the omentum”?
Bujalska, I. J., Kumar, S., & Stewart, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11222-8 · Cited by 753 · cited 2×
“increased expression of 11bHSD1 in human adipose stromal cells from omental compared with sc depots (21).”
Self-citationSex- and menopause-associated changes in body-fat distribution
Ley, C., Lees, B., & Stevenson, J. (1992) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.5.950 · Cited by 733
Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme
Albiston, A. L., Obeyesekere, V. R., Smith, R. E., & Krozowski, Z. S. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90176-7 · Cited by 712
(1996) · PubMed · Cited by 643
11β-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess*
White, P. C., Mune, T., & Agarwal, A. K. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0288 · Cited by 517
Cortisol secretion in relation to body fat distribution in obese premenopausal women
Mårin, P., Darin, N., Amemiya, T., Andersson, B., Jern, S., & Björntorp, P. (1992) · Metabolism · doi:10.1016/0026-0495(92)90171-6 · Cited by 458
Tannin, G. M., Agarwal, A. K., Monder, C., New, M. I., & White, P. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55351-5 · Cited by 436
Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
Stewart, P. M., Corrie, J. E., Shackleton, C. H., & Edwards, C. R. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113592 · Cited by 430
Self-citation
Cited by
Items 101–200 of 415
Adipose tissue and reproduction in women
BOHLER, H. C. L., Mokshagundam, S. L., & Winters, S. J. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.03.079 · Cited by 110
Weight Loss Increases 11β-Hydroxysteroid Dehydrogenase Type 1 Expression in Human Adipose Tissue
Tomlinson, J. W., Moore, J. S., Clark, P. M. S., Holder, G., Shakespeare, L., & Stewart, P. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031376 · Cited by 90
Self-citationTomlinson, J. W., Finney, J., Hughes, B. A., Hughes, S. V., & Stewart, P. M. (2008) · Diabetes · doi:10.2337/db08-0094 · Cited by 91
Self-citationAdipocyte biology in polycystic ovary syndrome
Barber, T. M., & Franks, S. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.10.010 · Cited by 104
Finken, M. J. J., Andrews, R. C., Andrew, R., & Walker, B. R. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.9.6009 · Cited by 88
Expanding the definition of hypothalamic obesity
Hochberg, I., & Hochberg, Z. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00727.x · Cited by 88
Livingstone, D. E. W., & Walker, B. R. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044842 · Cited by 99
Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats
Livingstone, D., Kenyon, C., & Walker, B. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1670533 · Cited by 87
Stimson, R. H., Johnstone, A. M., Homer, N. Z. M., Wake, D. J., Morton, N. M., Andrew, R., Lobley, G. E., & Walker, B. R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0692 · Cited by 83
Tomlinson, J. W. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.1.57 · Cited by 81
Self-citation11β-HSD1 Inhibitors for the Treatment of Type 2 Diabetes and Cardiovascular Disease
Anderson, A., & Walker, B. R. (2013) · Drugs · doi:10.1007/s40265-013-0112-5 · Cited by 90
Calcaterra, V., Regalbuto, C., Porri, D., Pelizzo, G., Mazzon, E., Vinci, F., Zuccotti, G., Fabiano, V., & Cena, H. (2020) · Biomolecules · doi:10.3390/biom10091324 · Cited by 90
Westgate, C. S. J., Botfield, H. F., Alimajstorovic, Z., Yiangou, A., Walsh, M. D., Smith, G., Singhal, R., Mitchell, J., Grech, O., Markey, K. A., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.145346 · Cited by 87
Draper, N., Echwald, S. M., Lavery, G. G., Walker, E. A., Fraser, R., Davies, E., Sørensen, T. I. A., Astrup, A., Adamski, J., Hewison, M., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011375 · Cited by 81
Self-citationNoppe, G., van den Akker, E. L. T., de Rijke, Y. B., Koper, J. W., Jaddoe, V. W. V., & van Rossum, E. F. C. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.113 · Cited by 91
Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes
Gathercole, L., & Stewart, P. M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.03.060 · Cited by 89
Self-citationA novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis
Bujalska, I. J., Gathercole, L. L., Tomlinson, J. W., Darimont, C., Ermolieff, J., Fanjul, A. N., Rejto, P. A., & Stewart, P. M. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0050 · Cited by 84
Self-citationInfluence of short-term dietary weight loss on cortisol secretion and metabolism in obese men
Johnstone, A., Faber, P., Andrew, R., Gibney, E., Elia, M., Lobley, G., Stubbs, R., & Walker, B. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500185 · Cited by 79
Liu, Y., Nakagawa, Y., Wang, Y., Li, R., Li, X., Ohzeki, T., & Friedman, T. C. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1409 · Cited by 79
Janković, D., Wolf, P. S., Anderwald, C. H., Winhofer, Y., Promintzer‐Schifferl, M., Hofer, A., Langer, F. B., Prager, G., Ludvik, B. H., Gessl, A., et al. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0545-4 · Cited by 86
Gender-Specific Differences in Skeletal Muscle 11β-HSD1 Expression Across Healthy Aging
Hassan-Smith, Z. K., Morgan, S. A., Sherlock, M., Hughes, B., Taylor, A. E., Lavery, G. G., Tomlinson, J. W., & Stewart, P. M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1516 · Cited by 77
Self-citationEasterbrook, J. D., Dunfee, R. L., Schwartzman, L. M., Jagger, B. W., Sandouk, A., Kash, J. C., Memoli, M. J., & Taubenberger, J. K. (2011) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2011.00254.x · Cited by 80
Glucocorticoid excess and hypertension
Baid, S. K., & Nieman, L. K. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0046-0 · Cited by 80
Adrenocortical activity in healthy children is associated with fat mass
Dimitriou, T., Maser‐Gluth, C., & Remer, T. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.3.731 · Cited by 80
Kumar, A., Aravamudhan, S., Gordic, M., Bhansali, S., & Mohapatra, S. S. (2006) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2006.09.035 · Cited by 82
Lavery, G. G., Zielinska, A. E., Gathercole, L. L., Hughes, B., Semjonous, N., Guest, P., Saqib, K., Sherlock, M., Reynolds, G., Morgan, S. A., et al. (2012) · Endocrinology · doi:10.1210/en.2012-1019 · Cited by 69
Self-citationTomlinson, J., & Stewart, P. M. (2005) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0023 · Cited by 82
Self-citationEvidence That the 11 β-Hydroxysteroid Dehydrogenase (11 β-HSD1) Is Regulated by Pentose Pathway Flux
McCormick, K. L., Wang, X., & Mick, G. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m506026200 · Cited by 72
11β-Hydroxysteroid dehydrogenase: unexpected connections
Walker, E. A., & Stewart, P. M. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(03)00134-6 · Cited by 72
Self-citationGardner, M. P., Lightman, S., Sayer, A. A., Cooper, C., Cooper, R., Deeg, D., Ebrahim, S., Gallacher, J., Kivimaki, M., Kumari, M., et al. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.04.016 · Cited by 72
Maternal obesity, metabolic disease, and allostatic load
Power, M. L., & Schulkin, J. A. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.09.011 · Cited by 77
Toogood, A. A., Taylor, N. F., Shalet, S. M., & Monson, J. P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6505 · Cited by 60
Stimson, R. H., Andrew, R., McAvoy, N. C., Tripathi, D., Hayes, P. C., & Walker, B. R. (2011) · Diabetes · doi:10.2337/db10-0726 · Cited by 67
Lois, K. B., & Kumar, S. (2009) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(09)73516-8 · Cited by 67
Self-citationRaverot, V., Richet, C., Morel, Y., Raverot, G., & Borson-Chazot, F. (2016) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.05.002 · Cited by 66
Nixon, M., Wake, D. J., Livingstone, D. E. W., Stimson, R. H., Esteves, C. L., Seckl, J. R., Chapman, K. E., Andrew, R., & Walker, B. R. (2012) · Diabetes · doi:10.2337/db11-0931 · Cited by 69
Walker, E. A., Ahmed, A., Lavery, G. G., Tomlinson, J. W., Kim, S. Y., Cooper, M. S., Ride, J. P., Hughes, B. A., Shackleton, C. H. L., McKiernan, P., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704144200 · Cited by 59
Self-citationHornby, C., Botfield, H. F., O’Reilly, M., Westgate, C. S. J., Mitchell, J., Mollan, S. P., Manolopoulos, K. N., Tomlinson, J., & Sinclair, A. J. (2017) · Neuro-Ophthalmology · doi:10.1080/01658107.2017.1334218 · Cited by 64
11β-Hydroxysteroid Dehydrogenase Activity in Hypothalamic Obesity
Tiosano, D., Eisentein, I., Militianu, D., Chrousos, G. P., & Hochberg, Z. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020511 · Cited by 62
Using animal models to study post‐partum psychiatric disorders
Perani, C. V., & Slattery, D. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12640 · Cited by 63
Stewart, P. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0633 · Cited by 62
Self-citationKorach-André, M., Gao, J., Gounarides, J., Deacon, R. W., Islam, A. H. M. W., & Laurent, D. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00089.2004 · Cited by 63
Cortisol: the villain in Metabolic Syndrome?
Paredes, S., & Ribeiro, L. V. P. T. (2014) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.60.01.017 · Cited by 74
Fructose, Glucocorticoids and Adipose Tissue: Implications for the Metabolic Syndrome
Legeza, B., Marcolongo, P., Gamberucci, A., Varga, V., Bánhegyi, G., Benedetti, A., & Odermatt, A. (2017) · Nutrients · doi:10.3390/nu9050426 · Cited by 66
Gelernter‐Yaniv, L., Feng, N., Sebring, N. G., Hochberg, Z., & Yanovski, J. A. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802327 · Cited by 65
Stomby, A., Andrew, R., Walker, B. R., & Olsson, T. (2014) · Diabetologia · doi:10.1007/s00125-014-3228-6 · Cited by 68
Berthiaume, M., Laplante, M., Festuccia, W. T., Cianflone, K., Turcotte, L. P., Joanisse, D. R., Olivecrona, G., Thieringer, R., & Deshaies, Y. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00276.2007 · Cited by 58
Sharma, R. P., Schuhmacher, M., & Kumar, V. (2016) · Environment International · doi:10.1016/j.envint.2016.09.016 · Cited by 61
Westerbacka, J., Cornér, A., Kannisto, K., Kolak, M., Makkonen, J., Korsheninnikova, E., Nyman, T., Hamsten, A., Fisher, R. M., & Yki‐Järvinen, H. (2005) · Diabetologia · doi:10.1007/s00125-005-0075-5 · Cited by 61
Obesity and Type 2 Diabetes Do Not Alter Splanchnic Cortisol Production in Humans
Basu, R., Singh, R. J., Basu, A., Chittilapilly, E. G., Johnson, M. C., Toffolo, G., Cobelli, C., & Rizza, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2390 · Cited by 58
Frajese, G. V., Taylor, N. F., Jenkins, P. J., Besser, G. M., & Monson, J. P. (2004) · Hormone Research in Paediatrics · doi:10.1159/000077135 · Cited by 56
Glucocorticoid Metabolism and Adrenocortical Reactivity to ACTH in Myotonic Dystrophy
Johansson, A. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4276 · Cited by 58
Función endocrina en la obesidad
Álvarez-Castro, P., Sangiao‐Alvarellos, S., Brandón-Sandá, I., & Cordido, F. (2011) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2011.05.015 · Cited by 79
Walker, B. R., & Seckl, J. R. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.6.771 · Cited by 57
Paulsen, S. K., Pedersen, S. B., Jørgensen, J. O. L., Fisker, S., Christiansen, J. S., Flyvbjerg, A., & Richelsen, B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1694 · Cited by 55
Vicennati, V., Ceroni, L., Genghini, S., Patton, L., Pagotto, U., & Pasquali, R. (2006) · Obesity · doi:10.1038/oby.2006.30 · Cited by 54
Hawley, J. M., & Keevil, B. G. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.05.014 · Cited by 55
Ignatova, I. D., Kostadinova, R. M., Goldring, C. E., Nawrocki, A. R., Frey, F. J., & Frey, B. M. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90531.2008 · Cited by 61
Activation of the hypothalamic-pituitary-adrenal axis in obesity: Cause or consequence?
Walker, B. R. (2001) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(01)80015-0 · Cited by 59
Painovich, J., SHUFELT, C. L., Azziz, R., Yang, Y., Goodarzi, M. O., Braunstein, G. D., Karlan, B. Y., Stewart, P. M., & Merz, C. N. B. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31821f9171 · Cited by 53
Self-citationWalker, B. R. (2007) · Proceedings of the Nutrition Society · doi:10.1017/s002966510700523x · Cited by 54
Tucker–Drob, E. M., Grotzinger, A. D., Briley, D. A., Engelhardt, L. E., Mann, F. D., Patterson, M. W., Kirschbaum, C., Adam, E. K., Church, J. A., Tackett, J. L., et al. (2017) · Psychological Medicine · doi:10.1017/s0033291716003068 · Cited by 52
Brereton, P. S., van Driel, R., Suhaimi, F. H., Koyama, K., Dilley, R., & Krozowski, Z. S. (2001) · Endocrinology · doi:10.1210/endo.142.4.8088 · Cited by 61
Palermo, M., Delitala, G., Mantero, F., Stewart, P. M., & Shackleton, C. H. L. (2001) · Journal of Endocrinological Investigation · doi:10.1007/bf03343803 · Cited by 52
Self-citationQuinkler, M., Oelkers, W., & Diederich, S. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440087 · Cited by 49
The pituitary–adrenal axis and body composition
Fernandez-Rodriguez, E., Stewart, P. M., & Cooper, M. S. (2009) · Pituitary · doi:10.1007/s11102-008-0098-2 · Cited by 49
Self-citationFarag, N. H., Moore, W. E., Lovallo, W. R., Mills, P. J., Khandrika, S., & Eichner, J. E. (2008) · Journal of Women's Health · doi:10.1089/jwh.2008.0866 · Cited by 46
Gambineri, A., Tomassoni, F., Munarini, A., Stimson, R. H., Mioni, R., Pagotto, U., Chapman, K. E., Andrew, R., Mantovani, V., Pasquali, R., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0091 · Cited by 55
Woods, C. P., Corrigan, M., Gathercole, L., TAYLOR, A. E. R., Hughes, B. A., Gaoatswe, G., Manolopoulos, K. N., Hogan, A. E., O’Connell, J., Stewart, P. M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4120 · Cited by 55
Self-citation11β-Hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes
Morgan, S., & Tomlinson, J. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.504713 · Cited by 51
Robert, O., Boujedidi, H., Bigorgne, A., Ferrere, G., Voican, C. S., Vettorazzi, S., Tuckermann, J. P., Bouchet‐Delbos, L., Tran, T., Hémon, P., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.023 · Cited by 48
Gout, J., Tirard, J., Thevenon, C., Riou, J. P., Bégeot, M., & Naville, D. (2006) · Biochimie · doi:10.1016/j.biochi.2006.05.020 · Cited by 59
Heise, T., Morrow, L., Hompesch, M., Häring, H., Kapitza, C., Abt, M., Ramsauer, M., Magnone, M. C., & Fuerst‐Recktenwald, S. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12317 · Cited by 50
Wang, Y., Yan, C., Liu, L., Wang, W., Du, H., Fan, W., Lutfy, K., Jiang, M., Friedman, T. C., & Liu, Y. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00205.2014 · Cited by 51
Makkonen, J., Westerbacka, J., Kolak, M., Sutinen, J., Cornér, A., Hamsten, A., Fisher, R. M., & Yki‐Järvinen, H. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803635 · Cited by 51
Lü, Y., Wang, E., Chen, Y., Zhou, B., Zhao, J., Xiang, L., Qian, Y., Jiang, J., Zhao, L., Xiong, X., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134485 · Cited by 46
Stewart, P. M., & Krone, N. P. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00015-8 · Cited by 61
Self-citationEnzymology and Molecular Biology of Glucocorticoid Metabolism in Humans
Blum, A., & Maser, E. (2003) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(03)75006-5 · Cited by 48
Homma, M., Tanaka, A., Hino, K., Takamura, H., Hirano, T., Oka, K., Kanazawa, M., Miwa, T., Notoya, Y., Niitsuma, T., et al. (2001) · Metabolism · doi:10.1053/meta.2001.24213 · Cited by 44
Toogood, Taylor, Shalet, & Monson (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00874.x · Cited by 42
Hepatic 11beta‐HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis
Konopelska, S., Kienitz, T., Hughes, B., Pirlich, M., Bauditz, J., Lochs, H., Strasburger, C. J., Stewart, P. M., & Quinkler, M. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03358.x · Cited by 41
Self-citationThieringer, R., & Hermanowski‐Vosatka, A. (2005) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.3.5.911 · Cited by 48
Cortisol, 11β-hydroxysteroid dehydrogenase type 1 and central obesity
Stewart, P. M., & Tomlinson, J. (2002) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(02)00566-0 · Cited by 50
Self-citationKatz, J., Taylor, N., Goodrick, S., Perry, L., Yudkin, J. S., & Coppack, S. W. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801122 · Cited by 48
Kerstens, M. N., Riemens, S. C., Sluiter, W. J., Pratt, J. J., Wolthers, B. G., & Dullaart, R. P. F. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00975.x · Cited by 43
Martins, C. S., Elias, D., Colli, L. M., Couri, C. E. B., Souza, M. C. L. A., Moreira, A. C., Foss, M. C., Elias, L. L. K., & de Castro, M. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2842 · Cited by 46
Álvarez-Castro, P., Sangiao‐Alvarellos, S., Brandón-Sandá, I., & Cordido, F. (2011) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2011.05.008 · Cited by 55
Apparent Cortisone Reductase Deficiency: A Rare Cause of Hyperandrogenemia and Hypercortisolism
Biason-Lauber, A., Suter, S. L., Shackleton, C. H. L., & Zachmann, M. (2000) · Hormone Research in Paediatrics · doi:10.1159/000023577 · Cited by 41
Self-citationGump, B. B., Reihman, J., Stewart, P., Lonky, E., Granger, D. A., & Matthews, K. A. (2009) · Health Psychology · doi:10.1037/a0015611 · Cited by 39
Self-citationMilk minerals and the metabolic syndrome
Scholz-Ahrens, K. E., & Schrezenmeir, J. (2006) · International Dairy Journal · doi:10.1016/j.idairyj.2006.06.009 · Cited by 44
Genetic manipulation of 11β-hydroxysteroid dehydrogenases in mice
Paterson, J. M., Seckl, J. R., & Mullins, J. J. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00017.2005 · Cited by 50
Stimson, R. H., & Walker, B. R. (2013) · hmbci · doi:10.1515/hmbci-2013-0015 · Cited by 38
Prevalence of Hypogonadism in Patients with Type 2 Diabetes Mellitus in an Asian Indian Study Group
Ganesh, H. K., Sarathi, V., George, J., Shivane, V. K., Bandgar, T., Menon, P. S., & Shah, N. S. (2009) · Endocrine Practice · doi:10.4158/ep09035.orr · Cited by 40
Prepubertal Glucocorticoid Status and Pubertal Timing
Shi, L., Wudy, S. A., Buyken, A. E., Maser‐Gluth, C., Hartmann, M. F., & Remer, T. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2935 · Cited by 40
11β-HSD1, Inflammation, Metabolic Disease and Age-related Cognitive (dys)Function
Chapman, K. E., & Seckl, J. R. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9504-9 · Cited by 47
Abujaber, F., Ricardo, A. I. C., Ríos, Á., Bernardo, F. J. G., & Martín-Doimeadios, R. C. R. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.12.001 · Cited by 38
Zebrafish: A New Promise to Study the Impact of Metabolic Disorders on the Brain
Ghaddar, B., & Diotel, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105372 · Cited by 41
Sönmez, A., Haymana, C., Bolu, E., Aydoğdu, A., Tapan, S., Serdar, M. A., Altun, B., Barçın, C., Taşlıpınar, A., Meriç, C., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0951 · Cited by 39
Tomlinson, J. W., Crabtree, N., Clark, P. M. S., Holder, G., Toogood, A. A., Shackleton, C. H. L., & Stewart, P. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021894 · Cited by 38
Self-citationMattsson, C., Lai, M., Noble, J., McKinney, E., Yau, J. L., Seckl, J. R., & Walker, B. R. (2003) · Endocrinology · doi:10.1210/en.2002-221015 · Cited by 39
Metadata
- Authors
- Stewart, P. M., Boulton, A., Kumar, S., Clark, P. M. S., & Shackleton, C. H. L.
- Affiliations
- Queen Elizabeth Hospital Birmingham (GB)
- National Health Service (GB)
- Corresponding author
- Stewart, Paul M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-03
- Volume
- 84
- Issue
- 3
- Pages
- 1022-1027
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2165935278
- Cited by
- 398
- References
- 43
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 5 · 2021: 2 · 2020: 11 · 2019: 4 · 2018: 3 · 2017: 10 · 2016: 10 · 2015: 19 · 2014: 18 · 2013: 10 · 2012: 19
- FWCI
- 14.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- cortisol metabolism, abdominal obesity, cortisone to cortisol conversion, 11β-hydroxysteroid dehydrogenase type 1, urinary free cortisol, dexamethasone suppression, ACTH, body fat distribution, glucocorticoid metabolism, obesity pathogenesis, insulin resistance
- MeSH terms
- Adipose Tissue, Adult, Body Constitution, Cortisone, Female, Humans, Hydrocortisone, Male, Obesity, Tetrahydrocortisol, Tetrahydrocortisone, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.